30/04/2019 12:15:00

NYSE: DPLO Investor Notice: Lawsuit against Diplomat Pharmacy Inc announced by Shareholders Foundation

SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in shares of Diplomat Pharmacy Inc (NYSE: DPLO). 

Investors, who purchased shares of Diplomat Pharmacy Inc (NYSE: DPLO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. 

The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that Diplomat Pharmacy Inc had downplayed its success in integrating and growing its PBM business, which included LDI Integrated and National Pharmaceutical, two companies Diplomat had acquired in late 2017, that consequently, Diplomat Pharmacy Inc would need to record a non-cash impairment charge upwards of approximately $630 million relating to its PBM business and these 2017 acquisitions, that due to the foregoing, Diplomat Pharmacy Inc would withdraw its preliminary 2019 full-year outlook issued less than seven weeks prior, and that as a result, defendants’ statements about Diplomat’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. 

Those who purchased Diplomat Pharmacy Inc (NYSE: DPLO) shares should contact the Shareholders Foundation, Inc.  

CONTACT:

Shareholders Foundation, Inc. 

Michael Daniels 

+1 (858) 779-1554 

mail@shareholdersfoundation.com 

3111 Camino Del Rio North 

Suite 423 

San Diego, CA 92108 

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon. 

Shareholders Foundation

Related content
26 Apr - 
APRIL 25 DEADLINE: Bragar Eagel & Squire, P.C. Announce..
25 Apr - 
APRIL 25 DEADLINE: Bragar Eagel & Squire, P.C. Announce..
25 Apr - 
The Klein Law Firm Reminds Investors of Class Actions o..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
ROHM's New Power Supply Monitoring IC with Built-In Self-Diagnostic Function that Supports Functional Safety
2
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sprint Corporation, Boston Scientific Corporation, Box, Inc. and Cloudera, Inc. and Encourages Investors to Contact the Firm
3
Genocea Announces Pricing of $36,750,000 Public Offering of Common Stock
4
Equity Trustees appointed Authorised Corporate Director to the AllianceBernstein UK OEIC
5
Atreca Announces Pricing of Initial Public Offering

Related stock quotes

Diplomat Pharmacy Inc 5.005 0.9% Stock price increasing

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 June 2019 01:07:46
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB7 - 2019-06-21 02:07:46 - 2019-06-21 01:07:46 - 1000 - Website: OKAY